Literature DB >> 34191227

Associations between sarcoidosis, autoimmune diseases, and autoantibodies: a single-center retrospective study in China.

Tian-Yan Shi1, Xiao-Hong Wen1, Xu-Hua Shi1, Juan Meng1, Yue-Wu Lu2.   

Abstract

To describe the clinical manifestations, immunological features, and risk factors in patients with sarcoidosis complicated with autoimmune diseases (ADs) as well as determine the frequency of autoantibodies and possible correlation between autoantibodies and laboratory data. Patients with pathologically confirmed sarcoidosis at Beijing Chaoyang Hospital (China) between January 2017 and October 2020 were included. Age- and sex-matched patients who visited the rheumatology outpatient clinic without systemic or ADs were included as controls. Demographic, clinical, serological, and radiological data of sarcoidosis patients were recorded and analyzed. To exclude ADs, autoantibodies, such as antinuclear antibody, extractable nuclear antigen antibodies, and anti-cyclic citrullinated peptide antibody were assessed in controls. A total of 154 sarcoidosis patients (111 females; 72.1%) with a mean ± standard deviation age of 50.7 ± 10.3 years were included. Nineteen patients (12.3%) had ADs; Hashimoto's thyroiditis (n = 6) and Sjogren's syndrome (n = 4) were common. Age, globulin, immunoglobulin G, erythrocyte sedimentation rate (ESR), and C-reactive protein were significantly different between sarcoidosis patients with and without ADs. The ESR level might be a risk factor for sarcoidosis complicated with ADs (RR = 1.053; P = 0.018). Autoantibodies were detected in 29 patients (18.8%), and the frequency was significantly higher than that in controls (18.8% vs. 3%; P = 0.001). Sarcoidosis patients were more likely to have autoantibodies despite the absence of ADs (10.4% vs. 3%; P = 0.031). Age may be a risk factor for sarcoidosis patients presenting with autoantibodies (RR = 1.077; P = 0.042). An association was identified between ADs and sarcoidosis. The inflammatory indexes, such as ESR, IgG, and CRP, were significantly different between sarcoidosis patients with and without ADs. ESR might be a risk factor for the coexistence of ADs and sarcoidosis. Sarcoidosis patients were prone to being autoantibody-positive despite the absence of ADs, and age might be a risk factor for sarcoidosis presenting with autoantibodies.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Autoantibodies; Autoimmune disease; Erythrocyte sedimentation rate; Risk factors; Sarcoidosis

Mesh:

Substances:

Year:  2021        PMID: 34191227     DOI: 10.1007/s10238-021-00737-5

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  8 in total

1.  Anti-cyclic citrullinated peptide antibodies in patients with sarcoidosis.

Authors:  Senol Kobak; H Ylmaz; F Sever; A Duran; N Sen
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2014-10-20       Impact factor: 0.670

Review 2.  Geoepidemiological big data approach to sarcoidosis: geographical and ethnic determinants.

Authors:  Pilar Brito-Zerón; Belchin Kostov; Daphne Superville; Robert P Baughman; Manuel Ramos-Casals
Journal:  Clin Exp Rheumatol       Date:  2019-08-26       Impact factor: 4.473

Review 3.  An epidemiological perspective of the pathology and etiology of sarcoidosis.

Authors:  Michiru Sawahata; Yukihiko Sugiyama
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2016-08-01       Impact factor: 0.670

Review 4.  The Diagnosis, Differential Diagnosis, and Treatment of Sarcoidosis.

Authors:  Antje Prasse
Journal:  Dtsch Arztebl Int       Date:  2016-08-22       Impact factor: 5.594

Review 5.  Erythrocyte Sedimentation Rate and C-reactive Protein Measurements and Their Relevance in Clinical Medicine.

Authors:  Christopher Bray; Lauren N Bell; Hong Liang; Rasha Haykal; Farah Kaiksow; Joseph J Mazza; Steven H Yale
Journal:  WMJ       Date:  2016-12

6.  The immunoglobulin and complement levels in the active pulmonary sarcoidosis.

Authors:  Tulin Cagatay; Muammer Bilir; Murat Gulbaran; Cigdem Papila; Penbe Cagatay
Journal:  Kobe J Med Sci       Date:  2003

7.  Sarcoidosis in Spain.

Authors:  J Mañá; F Badrinas; J Morera; E Fité; F Manresa; F Fernández-Nogués
Journal:  Sarcoidosis       Date:  1992-09

8.  The prevalence of antinuclear antibodies in patients with sarcoidosis.

Authors:  Senol Kobak; Hatice Yilmaz; Fidan Sever; Arzu Duran; Nazime Sen; Ahmet Karaarslan
Journal:  Autoimmune Dis       Date:  2014-12-17
  8 in total
  3 in total

Review 1.  Sarcoidosis and autoimmunity: In the depth of a complex relationship.

Authors:  Luigi Rizzi; Carlo Sabbà; Patrizia Suppressa
Journal:  Front Med (Lausanne)       Date:  2022-09-06

2.  Autoimmunity in sarcoidosis: the tip of the Iceberg.

Authors:  Konstantinos I Papadopoulos; Bengt Hallengren
Journal:  Clin Exp Med       Date:  2022-08-17       Impact factor: 5.057

3.  Microvascular capillaroscopic abnormalities and occurrence of antinuclear autoantibodies in patients with sarcoidosis.

Authors:  Francesco Cattelan; Elvis Hysa; Emanuele Gotelli; Carmen Pizzorni; Pietro Francesco Bica; Marco Grosso; Emanuela Barisione; Sabrina Paolino; Luca Carmisciano; Alberto Sulli; Vanessa Smith; Maurizio Cutolo
Journal:  Rheumatol Int       Date:  2022-08-30       Impact factor: 3.580

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.